An International Journal Clinical Rhinology

Register      Login

VOLUME 9 , ISSUE 2 ( May-August, 2016 ) > List of Articles

RESEARCH ARTICLE

Role of Hyaluronidase in Orbital Mass Excision

Pankaj Gupta, Suruchi Gupta, Amit Poredi, Zoramthara Zadeng

Keywords : Hyaluronidase,Orbital mass,Orbitotomy

Citation Information : Gupta P, Gupta S, Poredi A, Zadeng Z. Role of Hyaluronidase in Orbital Mass Excision. Clin Rhinol An Int J 2016; 9 (2):81-83.

DOI: 10.5005/jp-journals-10013-1274

Published Online: 01-08-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background

Hyaluronidase belongs to a family of enzymes that degrades hyaluronic acid, which is a constituent of the extracellular matrix. The property of hyaluronidase to help relieve tissue adhesions has found implications in epidural neuroplasty, failed back surgery syndrome, abdominal adhesions, and in prevention of formation of adhesions postoperatively in laparoscopic ventral hernia repair. There is no previous study supporting the role of hyaluronidase in relieving the adhesions around the orbital masses and aiding in their delivery. This article intends to discuss the utility of hyaluronidase in orbital mass excision by relieving adhesions around the mass.

Aim

The purpose of this article is to describe the successful use of hyaluronidase intraoperatively for excision of orbital cavernous hemangioma. This patient had an orbital cavernous hemangioma of 8 years’ duration.

Materials and methods

This report describes a patient who presented with unilateral proptosis of long-standing duration and visual diminution of 6 months’ duration. Radiological imaging showed presence of intraconal cavernous hemangioma in the right orbit. The patient underwent transconjunctival orbitotomy for orbital mass excision. Intraoperatively, 5 mL of injection hyaluronidase 300 IU/mL diluted in balanced salt solution was injected around the mass for adhesiolysis using a 25-gauge cannula.

Conclusion

The intraoperative use of hyaluronidase helped in relieving the adhesions around the mass and helped in its easy delivery without undue manipulation.

Clinical significance

Hyaluronidase is helpful in adhesiolysis around the orbital masses and promotes their easy delivery. This helps in early recovery and decreased postoperative tissue edema. This is first such report implicating the role of hyaluronidase in orbital mass excision.

How to cite this article

Gupta P, Gupta S, Poredi A, Zadeng Z. Role of Hyaluronidase in Orbital Mass Excision. Clin Rhinol An Int J 2016;9(2):81-83.


PDF Share
  1. A recombinant human enzyme for enhanced interstitial transport of therapeutics. J Control Release 2006 Aug 28;114(2):230-241.
  2. Retrobulbar anaesthesia: the role of hyaluronidase. Anaesth Analg 1986 Dec;65(12):1324-1328.
  3. Value of hyaluronidase in ocular surgical akinesia. Am J Ophthalmol 1978 May;85(5 Pt 1):643-646.
  4. Hyaluronidase in the management of pain due to postlaminectomy scar tissue. Pain 1994 Aug;58(2):273-276.
  5. The effect of hyaluronidase in interlaminar lumbar epidural injection for failed back surgery syndrome. Ann Rehabil Med 2012 Aug;36(4):466-473.
  6. A report on 6 cases of adhesive bowel obstruction treated with major Rhubarb combination and sodium hyaluronate. Chin J Surg Integr Tradit West Med 2001;7(1): 32-33.
  7. Use of hyaluronidase cream to prevent peritoneal adhesions in laparoscopic ventral hernia repair by means of intraperitoneal mesh fixation using spiral tacks. Surg Endosc 2008 Mar;22(3):631-634.
  8. Subcutaneous rehydration: updating a traditional technique. Pediatr Emerg Care 2011 Mar;27(3):230-236.
  9. Recombinant human hyaluronidase enabled subcutaneous pediatric rehydration. Pediatrics 2009 Nov;124(5):e858-e867.
  10. Recombinant human hyaluronidase facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency. J Allergy Clin Immunol 2012 Oct;130(4):951-957. e11.
  11. An introductory overview of orbital tumors. Neurosurg Focus 2001 May;10(5):E1.
  12. Surgical approaches to the orbit: indications and technique. J Neurosurg 1984 Jun;60(6):1226-1235.
  13. Surgical approaches to orbital tumors. Clin Plast Surg 1988 Apr;15(2):273-282.
  14. Surgical treatment of orbital tumors at a single institution. J Korean Neurosurg Soc 2008 Sep;44(3):146-150.
  15. Lateral orbitotomy approach to orbital tumors: report of 10 cases. Turk Neurosurg 2010 Apr;20(2):167-172.
  16. Surgical outcomes of transconjunctival anterior orbitotomy for intraconal orbital cavernous haemangioma. Korean J Ophthalmol 2010 Oct;24(5):274-278.
  17. Transconjunctival surgery. Ophthalmic Surg 1992 Apr;23(4):288-291.
  18. Complications of the transconjunctival approach: a review of 400 cases. Arch Otolaryngol Head Neck Surg 1997 Apr;123(4):385-388.
  19. Hyaluronidase in ophthalmic anesthesia. Anaesth Analg 2001 Feb;92(2):560.
  20. Hyaluronidase. Br J Anaesth 1993 Sep;71(3):422-425.
  21. Effect of hyaluronidase on capillary permeability, lymph flow, and passage of dye-labelled protein from plasma to lymph. Nature 1958 Aug 9;182(4632):377-379.
  22. The management of chronic spinal pain by blockade: a review. Pain 1994 Jul;58(1):1-20.
  23. Hypodermoclysis: an alternative infusion technique. Am Fam Physician 2001 Nov 1;64(9):1575-1579.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.